-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesRead moreTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingRead moreEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeRead moreEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Read moreThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Regulation
-
About Euronext
Euronext strategic planInnovate for Growth 2027Read moreShaping capital markets for future generations
-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesRead moreTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingRead moreEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeRead moreEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Read moreThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Regulation
-
About Euronext
Euronext strategic planInnovate for Growth 2027Read moreShaping capital markets for future generations
- Home
- About
- Media centre
- Bell Ceremony Archive
- Borstkankervereniging – Breastcancer awareness month
Borstkankervereniging – Breastcancer awareness month
09/10/2019
Goli Abdurahman, active member of Borstkankervereniging Nederland, opened the stock exchange to draw more attention for people with breastcancer or genetic predisposition for breastcancer.
About breastcancer awareness month
October is Breast Cancer Awareness Month, an annual campaign to increase awareness of the disease. Every year, more than 17.000 Dutch women and more than 100 men get breast cancer. Breast cancer has many faces. There are different types of breast cancer and all kinds of people are affected by it: young women, older women, people with metastatic breast cancer, with hereditary predisposition to breast cancer and men. Every patient experiences breast cancer differently. Not only when it comes to treatment, but also when it comes to consequences. From chronic fatigue to sexual problems. From physical complaints to misunderstanding at work. From fear of return to broken relationships. Support all these people in October.
About Borstkankervereniging Nederland
Borstkankervereniging Nederland is a professional patient organization for everyone who has (had) to deal with breast cancer, or has a hereditary or familial predisposition to breast cancer. BVN strives for optimum quality of care and the best possible quality of life. BVN does this by providing good, up-to-date information, organizing contact with fellow sufferers and promoting the interests of breast cancer patients. BVN brings the patient perspective to the attention of hospitals, care providers, researchers, health insurers and other stakeholders. In this way, patient experiences and patient interests get a valuable place in policy and research.
For more information: www.borstkanker.nl